کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3909891 | 1251234 | 2008 | 7 صفحه PDF | دانلود رایگان |
Although not curable, advanced breast cancer is treatable, however, treatment options are many and varied, and unlike early breast cancer (EBC), consistent guidelines are lacking. Breast cancer physicians were surveyed to assess the emotional impact of recurrence, factors affecting their treatment decisions, the role of guidelines in the management of advanced breast cancer and the need for new guidelines. Overall, distress levels were higher at recurrence than at first diagnosis of early breast cancer for both patients and physicians and the goal of treatment for this disease stage was to improve the patient's quality of life, delay disease progression and improve overall survival. While most respondents (96%) use the currently available guidelines, improvements are required, including the development of uniform global guidelines and recommendations for specific patient groups. Interactive computer programs and e-mail updates should also be utilised to ensure physicians are able to make fully informed decisions regarding optimum treatment.
Journal: The Breast - Volume 17, Issue 3, June 2008, Pages 275–281